ILMN

Illumina, Inc.

September 16, 2026 · after-hours

Rarity

1.35

Peak move

+7.54%

Float cap

$34.9B

Illumina provides sequencing- and array-based solutions for genetic and genomic analysis. Its integrated systems, consumables, and analysis tools are used by genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical and biotechnology companies, diagnostic laboratories, and consumer genomics firms. The company serves research, applied, and clinical markets, including oncology, genetic health, and reproductive health.

• major_contracttime: see source

  Novacyt S.A. entered a five-year Master Collaboration Agreement with Illumina, creating a framework for separate project-based product development and commercial deals without upfront capital commitments.

  Websimplywall.st
• index_rebalanceSep 13 · 17:50 ET

  S&P Dow Jones Indices announced Illumina will replace Builders FirstSource in the S&P 500 before the market opens on September 21, 2026, moving up from the S&P MidCap 400 as part of the quarterly rebalance, about 27 months after S&P Dow Jones Indices removed it on June 24, 2024, when it spun off GRAIL.

  Webtikr.comWebtikr.comWebbarchart.comWebweissratings.comWebpress.spglobal.com
• peer_disclosureJul 14 · 08:00 ET

  Element Biosciences said the Regional Court of Munich I ruled that Illumina and Illumina GmbH infringe its DNA-sequencing imaging patent, ordering an injunction and recall of MiSeq/MiSeqDx systems and consumables sold in Germany since March 31, 2023, with damages liability.

  Webelementbiosciences.comWebsimplywall.st
• product_launchMay 28

  Illumina launched a whole-genome sequencing research workflow for molecular residual disease detection with early access for select clinical research partners, about five days processing, 10 ppm analytical sensitivity and DRAGEN analysis at 99.5% specificity, with broader commercial launch planned for next year.

  Webttmblog.com
• major_contractApr 14

  Illumina announced a collaboration with the Biomedical Data-Driven Discovery Center to integrate genomic data resources and scalable software tools for paediatric cancer and rare disease research.

  Webitiger.com